Aprea Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:APRE) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -3.51 M-3.63 M-3.13 M-3.17 M-2.96 M-2.76 M -12.02 M Cash from investing activities 0-7 978-7 50000— — Cash from financing activities 134.41 K55.85 K384.88 K357.94 K3.84 M34.62 M 39.21 M Free cash flow -3.51 M-3.63 M-3.13 M-3.17 M-2.96 M-2.76 M -12.02 M

News

Aprea Therapeutics (APRE) Upgraded to Buy: Here's What You Should Know

H.C. Wainwright reiterates Aprea stock rating, keeps $4 target

Aprea Therapeutics Advanced Cancer Trial Shows Promising Results, Stock Soars - Aprea Therapeutics (NASDAQ:APRE)

Aprea reports second partial response in endometrial cancer trial

Aprea Therapeutics appoints Eugene Kennedy as chief medical advisor

Aprea Therapeutics (APRE) CEO buys $25,000 in shares

Aprea Therapeutics stock falls after early-stage cancer drug data

Aprea Therapeutics raises $5.6 million in private placement

Aprea reports first partial response in Phase 1 cancer drug trial

New Strong Sell Stocks for January 19th

New Strong Sell Stocks for Jan. 14

Aprea Therapeutics reports progress in cancer drug development